All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Not reported | 2004-002076-42 | Safety, hemostatic and metabolic effects and contraceptive efficacy of an oral monophasic contraceptive containing 0.03 mg ethinylestradiol and 2 mg chlormadinone acetate (CG5025) used in two differen... | 2006-02-09 | due-trials |
| Reported results | 2004-003035-31 | Safety of the oral monophasic contraceptive GRT4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 mg desogestrel given for 6 medication cycles Ra... | 2016-07-21 | due-trials |
| Reported results | 2005-001404-40 | Cross-over multiple dose study assessing the analgesic efficacy and safety of oral GRT9906 PR compared to active comparator and placebo in subjects with painful polyneuropathy of mixed origin | 2006-08-21 | due-trials |
| Reported results | 2005-001656-21 | A randomized, multi-center, double-blind, parallel-group, multiple-dose study assessing the analgesic efficacy and safety of 3 different doses of GRT0151Y compared to placebo and an active comparator ... | 2006-02-17 | due-trials |
| Reported results | 2005-003360-26 | A randomized, multi-centre, double blind, parallel-group study assessing the analgesic efficacy and safety of different dosages of GRT0151Y bid compared to active comparator bid and placebo bid in sub... | 2006-08-11 | due-trials |
| Reported results | 2005-005365-11 | A randomised, 2-arm, parallel group study assessing efficacy and tolerability of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain | 2006-08-03 | due-trials |
| Reported results | 2006-003132-29 | Eficacia y Seguridad de un parche de lidocaína al 5% comparado con pregabalina en neuralgia post-herpética y dolor por polineuropatía diabética. | 2008-01-14 | due-trials |
| Reported results | 2006-003482-14 | A One-Year, Randomized, Open-Label, Parallel-Arm, Phase III Long-Term Safety Trial, with Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR and Oxycodone CR in Subjects with Chronic Pain | 2018-07-28 | due-trials |
| Reported results | 2006-004997-28 | A randomized withdrawal, active- and placebo-controlled, double-blind, multi-center Phase III trial assessing safety and efficacy of oral CG5503 PR in subjects with moderate to severe chronic malignan... | 2012-06-19 | due-trials |
| Reported results | 2006-004998-95 | A randomized, double-blind, parallel-arm, placebo- and comparator-controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 for postoperative pain following abdomi... | 2008-02-16 | due-trials |
| Reported results | 2006-005783-67 | A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Prolonged-Release (PR) in Subject... | 2008-07-18 | due-trials |
| Reported results | 2008-004794-18 | A randomized Phase IIa trial evaluating the safety and efficacy of a new centrally acting analgesic in subjects with pain due to diabetic polyneuropathy | 2010-05-25 | due-trials |
| Reported results | 2009-010423-58 | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chroni... | 2010-09-10 | due-trials |
| Reported results | 2009-010425-39 | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic pain due to... | 2010-08-12 | due-trials |
| Reported results | 2009-010427-12 | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chroni... | 2010-07-06 | due-trials |
| Reported results | 2009-010428-25 | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nociceptive... | 2011-01-21 | due-trials |
| Reported results | 2009-013291-46 | Ensayo clínico de Fase III abierto, de un solo grupo y con dosificación flexible de tapentadol LP oral en pacientes con dolor tumoral crónico que hayan completado el Periodo de Mantenimiento del estud... | 2014-05-29 | due-trials |
| Reported results | 2009-015397-35 | A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-rel... | 2010-09-03 | due-trials |
| Reported results | 2009-015527-82 | Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb ... | 2011-12-14 | due-trials |
| Reported results | 2009-016337-10 | Lidocaine 5% medicated plaster for the topical treatment of localized chronic postoperative neuropathic pain after total knee replacement or thoracotomy | 2012-11-27 | due-trials |
| Reported results | 2009-017470-20 | An open-label extension study for patients with severe chronic low back pain or severe chronic pain due to knee osteoarthritis who have completed any of the previous phase IIIb trials with tapentadol ... | 2014-02-23 | due-trials |
| Reported results | 2010-019998-14 | Evaluación de la efectividad, seguridad y tolerabilidad de tapentadol de liberación prolongada frente a una combinación de tapentadol de liberación prolongada y pregabalina en pacientes con lumbalgia... | 2012-01-17 | due-trials |
| Reported results | 2010-022556-23 | A randomized 4 week Phase IIa trial evaluating the efficacy, safety, and tolerability of GRT6005, a new centrally acting analgesic in subjects with moderate to severe pain due to osteoarthritis (OA) o... | 2011-12-15 | due-trials |
| Reported results | 2010-022557-42 | A randomized 4-week Phase IIa trial evaluating the efficacy, safety, and tolerability of GRT6005, a new centrally acting analgesic, in subjects with pain due to diabetic polyneuropathy. | 2012-01-05 | due-trials |
| Reported results | 2011-002092-42 | Evaluation of the efficacy, tolerability, and safety of 7 days of treatment with GRT6010 or pregabalin in comparison to placebo in subjects with peripheral neuropathic pain. | 2013-01-18 | due-trials |
| Reported results | 2012-000347-28 | Efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain | 2016-06-21 | due-trials |
| Reported results | 2012-001316-35 | Efficacy, safety, and tolerability of oral Cebranopadol versus morphine sulphate PR in subjects with chronic moderate to severe pain related to cancer. | 2015-10-16 | due-trials |
| Reported results | 2012-001920-36 | Efficacy, safety, and tolerability of GRT6005 in subjects with moderate to severe chronic low back pain | 2014-07-10 | due-trials |
| Reported results | 2012-002943-11 | Evaluation of the effectiveness, safety, and tolerability of tapentadol PR versus oxycodone/naloxone PR in non-opioid pre-treated subjects with uncontrolled severe chronic low back pain with a neuropa... | 2014-01-28 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2012-004359-35 | An evaluation of the efficacy and safety of tapentadol oral solution in the treatment of post-operative acute pain requiring opioid treatment in pediatric subjects aged from birth to less than 18 year... | 2019-03-14 | bad-data |
| Reported results | 2012-004360-22 | An open label trial, enrolling subjects aged 6 years to less than 18 years suffering from pain requiring prolonged release opioid treatment, to evaluate the safety and efficacy of tapentadol PR versus... | 2018-10-15 | due-trials |
| Reported results | 2012-005499-33 | Relative bioavailability trial to investigate the pharmacokinetics of tapentadol following the administration of 3 prototype tapentadol 25 mg prolonged release (PR) granule formulations compared to a ... | 2015-06-15 | due-trials |
| Reported results | 2013-000473-68 | Efficacy, safety and tolerability of multiple doses of oral cebranopadol in subjects with moderate to severe chronic pain due to diabetic peripheral neuropathy | 2015-01-28 | due-trials |
| Reported results | 2013-001877-26 | An open-label, multi-site trial to describe the safety and tolerability of oral cebranopadol administered for 26 weeks in subjects with cancer-related pain who have completed treatment in the KF6005/0... | 2016-05-03 | due-trials |
| Trial is outside EEC, and reported results | 2013-002016-27 | Open-label evaluation of the pharmacokinetic profile, safety, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children and adolescents aged from 2 years to less tha... | bad-data | |
| Reported results Terminated | 2014-000623-24 | Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children aged from birth to l... | 2016-12-14 | due-trials |
| Reported results | 2014-001915-37 | A randomized, double-blind trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome type I (CRPS-I) | 2016-11-02 | due-trials |
| Reported results | 2014-002259-24 | Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of intravenous tapentadol solution for injection for the treatment of post-surgical pain in children... | 2018-09-27 | due-trials |
| Reported results | 2016-001164-11 | Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) | 2019-01-09 | due-trials |
| Completed, but no date, and reported results | 2016-002259-11 | A multicenter, open-label, single-arm, Phase IIIb trial to evaluate the effectiveness, safety, tolerability, usability and health economics resource utilization of Zalviso® for management of acute mod... | bad-data | |
| Reported results | 2016-002611-18 | An exploratory, randomized, double-blind, double-dummy, placebo- and active-controlled Phase II trial to evaluate the efficacy and safety of a topical application of GRT7019 in subjects with chronic p... | 2018-01-17 | due-trials |
| Reported results | 2016-003833-91 | Randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) Ensayo aleatorizado, d... | 2019-07-31 | due-trials |
| Reported results | 2016-003940-35 | Exploratory, randomized, double-blind, placebo-controlled evaluation of efficacy, tolerability, and safety of intravesical instillation of GRT6010 compared to placebo in subjects with bladder pain syn... | 2018-05-02 | due-trials |
| Reported results | 2017-004244-37 | Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) Placebem kontrolované klinické hodnocení účinnosti a bezpečnosti i... | 2019-08-01 | due-trials |
| Reported results | 2018-000818-37 | A randomized, double-blind, placebo-controlled, single dose phase IIb exploratory study to document the clinical effects and safety of intra-articular injections of Lopain (MTX-071) in patients with c... | 2023-01-26 | due-trials |
| Reported results | 2019-000205-77 | Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged 2 ... | 2020-08-06 | due-trials |
| Listed as ongoing, but also has a completion date | 2021-005020-38 | A randomized, double-blind, placebo-controlled, Phase III trial to evaluate the efficacy and safety of a single intra-articular injection of RTX-GRT7039 in adult subjects with pain associated with ost... | 2024-08-15 | bad-data |
| Completed, but no date | 2021-005029-26 | A randomized, double-blind, placebo-controlled, Phase III trial to evaluate the efficacy and safety of intra-articular injections of RTX-GRT7039 in adult subjects with pain associated with osteoarthri... | bad-data | |
| Other | 2021-005046-15 | A single-arm, open-label, Phase III trial to evaluate the safety and tolerability of intra-articular injections of RTX-GRT7039 in subjects with moderate to severe pain associated with osteoarthritis o... | not-yet-due |